FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1686298519> ?p ?o ?g. }

• W1686298519 abstract "Many clinical trials have shown the efficacy of aromatase inhibitors (AIs) in the management of breast cancer (BC). There is growing evidence that CYP19A1 single-nucleotide polymorphisms (SNPs) are associated with clinical response (CR) and adverse effects (AEs) among BC patients treated with AIs. The aim of this study was to analyze the association between CYP19A1 polymorphisms and AI treatment in BC patients. A systematic review was performed in MEDLINE, EMBASE, and LILACS. A meta-analysis was conducted to compare the association between CYP19A1 variants and treatment response among BC patients. A total of 12 studies were included in the final analysis. There was significant variation among the populations studied and the SNPs and outcomes investigated. A meta-analysis was only possible for the evaluation of SNP rs4646 vs. the wild-type variant with respect to time to progression (TTP) among metastatic BC patients treated with AI. TTP was significantly increased in patients with the rs4646 variant compared with the wild-type gene (hazard ratio (HR) = 0.51 [95 % confidence interval (CI), 0.33–0.78], P = 0.002). Seven studies analyzed the association between AEs with different polymorphisms of CYP19A1. Although there was a statistically significant association with musculoskeletal adverse events (rs934635, rs60271534, rs700518rs, and haplotype M_3_5) and with vasomotor symptoms (rs934635, rs1694189, rs7176005, and haplotype M_5_3) in individual studies, similar associations were not observed in further studies. No statistically significant association between musculoskeletal AEs and SNPs rs4646, rs10046, rs727479, and rs1062033 was found. These findings suggest that the presence of the rs4646 variant may be a predictive factor of the benefit of AI treatment for BC. The effects of CYP19A1 polymorphisms on clinical outcomes were most often detected in individual studies, suggesting that longer-term studies will better clarify these associations. Additional studies are needed to clarify the predictive value of other SNPs and whether CYP19A1 genotyping should be used to guide AI treatment." @default.
• W1686298519 created "2016-06-24" @default.
• W1686298519 creator A5021968370 @default.
• W1686298519 creator A5023260101 @default.
• W1686298519 creator A5061102448 @default.
• W1686298519 creator A5073819679 @default.
• W1686298519 creator A5085356021 @default.
• W1686298519 date "2015-06-11" @default.
• W1686298519 modified "2023-10-07" @default.
• W1686298519 title "Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis" @default.
• W1686298519 cites W13603561 @default.
• W1686298519 cites W1529243395 @default.
• W1686298519 cites W1595237219 @default.
• W1686298519 cites W1961026612 @default.
• W1686298519 cites W1967362060 @default.
• W1686298519 cites W1972276952 @default.
• W1686298519 cites W1980255186 @default.
• W1686298519 cites W1980855186 @default.
• W1686298519 cites W1985919197 @default.
• W1686298519 cites W2003528564 @default.
• W1686298519 cites W2005309422 @default.
• W1686298519 cites W2015473392 @default.
• W1686298519 cites W2020830322 @default.
• W1686298519 cites W2029519754 @default.
• W1686298519 cites W2030790518 @default.
• W1686298519 cites W2030860590 @default.
• W1686298519 cites W2042159973 @default.
• W1686298519 cites W2056544643 @default.
• W1686298519 cites W2058408716 @default.
• W1686298519 cites W2065695234 @default.
• W1686298519 cites W2076084884 @default.
• W1686298519 cites W2085921275 @default.
• W1686298519 cites W2086849507 @default.
• W1686298519 cites W2100423933 @default.
• W1686298519 cites W2101881391 @default.
• W1686298519 cites W2103313189 @default.
• W1686298519 cites W2106787323 @default.
• W1686298519 cites W2107763907 @default.
• W1686298519 cites W2107932490 @default.
• W1686298519 cites W2112780046 @default.
• W1686298519 cites W2115776903 @default.
• W1686298519 cites W2117301449 @default.
• W1686298519 cites W2129539758 @default.
• W1686298519 cites W2133940850 @default.
• W1686298519 cites W2135230337 @default.
• W1686298519 cites W2144133819 @default.
• W1686298519 cites W2145408637 @default.
• W1686298519 cites W2146194560 @default.
• W1686298519 cites W2147993322 @default.
• W1686298519 cites W2148902690 @default.
• W1686298519 cites W2150082844 @default.
• W1686298519 cites W2156098321 @default.
• W1686298519 cites W2170015870 @default.
• W1686298519 cites W2170187210 @default.
• W1686298519 cites W2170334909 @default.
• W1686298519 cites W246286872 @default.
• W1686298519 cites W28052452 @default.
• W1686298519 cites W4294215472 @default.
• W1686298519 doi "https://doi.org/10.1186/s12916-015-0373-9" @default.
• W1686298519 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4475294" @default.
• W1686298519 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26067721" @default.
• W1686298519 hasPublicationYear "2015" @default.
• W1686298519 type Work @default.
• W1686298519 sameAs 1686298519 @default.
• W1686298519 citedByCount "36" @default.
• W1686298519 countsByYear W16862985192015 @default.
• W1686298519 countsByYear W16862985192016 @default.
• W1686298519 countsByYear W16862985192017 @default.
• W1686298519 countsByYear W16862985192018 @default.
• W1686298519 countsByYear W16862985192019 @default.
• W1686298519 countsByYear W16862985192020 @default.
• W1686298519 countsByYear W16862985192021 @default.
• W1686298519 countsByYear W16862985192022 @default.
• W1686298519 countsByYear W16862985192023 @default.
• W1686298519 crossrefType "journal-article" @default.
• W1686298519 hasAuthorship W1686298519A5021968370 @default.
• W1686298519 hasAuthorship W1686298519A5023260101 @default.
• W1686298519 hasAuthorship W1686298519A5061102448 @default.
• W1686298519 hasAuthorship W1686298519A5073819679 @default.
• W1686298519 hasAuthorship W1686298519A5085356021 @default.
• W1686298519 hasBestOaLocation W16862985191 @default.
• W1686298519 hasConcept C104317684 @default.
• W1686298519 hasConcept C121608353 @default.
• W1686298519 hasConcept C126322002 @default.
• W1686298519 hasConcept C135763542 @default.
• W1686298519 hasConcept C139275648 @default.
• W1686298519 hasConcept C143998085 @default.
• W1686298519 hasConcept C153209595 @default.
• W1686298519 hasConcept C197754878 @default.
• W1686298519 hasConcept C197934379 @default.
• W1686298519 hasConcept C207103383 @default.
• W1686298519 hasConcept C2775860665 @default.
• W1686298519 hasConcept C2776166826 @default.
• W1686298519 hasConcept C29456083 @default.
• W1686298519 hasConcept C44249647 @default.
• W1686298519 hasConcept C530470458 @default.
• W1686298519 hasConcept C54355233 @default.
• W1686298519 hasConcept C60644358 @default.
• W1686298519 hasConcept C71924100 @default.
• W1686298519 hasConcept C86803240 @default.

• next